↓ Skip to main content

Cochrane Database of Systematic Reviews

Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria

Overview of attention for article published in Cochrane database of systematic reviews, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news
1 news outlet
twitter
12 X users
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
245 Mendeley
Title
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
Published in
Cochrane database of systematic reviews, October 2014
DOI 10.1002/14651858.cd010340.pub2
Pubmed ID
Authors

Arturo J Martí‐Carvajal, Vidhu Anand, Andrés Felipe Cardona, Ivan Solà

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic, not malignant, disease of the hematopoietic stem cells, associated with significant morbidity and mortality. It is a rare disease with an estimated incidence of 1.3 new cases per one million individuals per year. The treatment of PNH has been largely empirical and symptomatic, with blood transfusions, anticoagulation, and supplementation with folic acid or iron. Eculizumab, a biological agent that inhibits complement cascade, was developed for preventing hemolytic anemia and severe thrombotic episodes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 245 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 245 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 18%
Researcher 25 10%
Student > Bachelor 22 9%
Student > Doctoral Student 19 8%
Student > Ph. D. Student 18 7%
Other 40 16%
Unknown 78 32%
Readers by discipline Count As %
Medicine and Dentistry 79 32%
Nursing and Health Professions 26 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Psychology 9 4%
Biochemistry, Genetics and Molecular Biology 8 3%
Other 32 13%
Unknown 81 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2023.
All research outputs
#1,986,191
of 26,103,952 outputs
Outputs from Cochrane database of systematic reviews
#4,083
of 13,187 outputs
Outputs of similar age
#22,104
of 276,102 outputs
Outputs of similar age from Cochrane database of systematic reviews
#92
of 249 outputs
Altmetric has tracked 26,103,952 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,187 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.4. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,102 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 249 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.